Genetic and environmental circadian disruption induce weight gain through changes in the gut microbiome.

Mol Metab

ZIEL - Institute for Food & Health, Technical University of Munich, Gregor-Mendel Str. 2, 85354 Freising, Germany; Chair of Nutrition and Immunology, Technical University of Munich, Gregor-Mendel-Str. 2, 85354 Freising, Germany; Faculty of Health and Biomedical Science, University of Surrey, 388 Stagg Hill Campus, GU27XH, Guildford, UK. Electronic address:

Published: December 2022

AI Article Synopsis

  • The text discusses how internal biological clocks regulate behavior, physiology, and gut microbiome health in a 24-hour cycle, with disruptions (e.g., from shift work) leading to obesity and type 2 diabetes (T2D).
  • Research involved examining clock gene activity and gut microbiota in mice models with circadian disruptions to assess impacts on body weight, energy balance, and microbial composition.
  • Findings reveal that both disruption models show loss of synchrony in the gut's internal clocks and diminished microbial function, correlating with weight gain and metabolic issues, highlighting an important link between circadian rhythms, gut health, and obesity.

Article Abstract

Objective: Internal clocks time behavior and physiology, including the gut microbiome, in a circadian (∼24 h) manner. Mismatch between internal and external time, e.g. during shift work, disrupts circadian system coordination promoting the development of obesity and type 2 diabetes (T2D). Conversely, body weight changes induce microbiota dysbiosis. The relationship between circadian disruption and microbiota dysbiosis in metabolic diseases, however, remains largely unknown.

Methods: Core and accessory clock gene expression in different gastrointestinal (GI) tissues were determined by qPCR in two different models of circadian disruption - mice with Bmal1 deficiency in the circadian pacemaker, the suprachiasmatic nucleus (Bmal1), and wild-type mice exposed to simulated shift work (SSW). Body composition and energy balance were evaluated by nuclear magnetic resonance (NMR), bomb calorimetry, food intake and running-wheel activity. Intestinal permeability was measured in an Ussing chamber. Microbiota composition and functionality were evaluated by 16S rRNA gene amplicon sequencing, PICRUST2.0 analysis and targeted metabolomics. Finally, microbiota transfer was conducted to evaluate the functional impact of SSW-associated microbiota on the host's physiology.

Results: Both chronodisruption models show desynchronization within and between peripheral clocks in GI tissues and reduced microbial rhythmicity, in particular in taxa involved in short-chain fatty acid (SCFA) fermentation and lipid metabolism. In Bmal1SCNfl/- mice, loss of rhythmicity in microbial functioning associates with previously shown increased body weight, dysfunctional glucose homeostasis and adiposity. Similarly, we observe an increase in body weight in SSW mice. Germ-free colonization experiments with SSW-associated microbiota mechanistically link body weight gain to microbial changes. Moreover, alterations in expression of peripheral clock genes as well as clock-controlled genes (CCGs) relevant for metabolic functioning of the host were observed in recipients, indicating a bidirectional relationship between microbiota rhythmicity and peripheral clock regulation.

Conclusions: Collectively, our data suggest that loss of rhythmicity in bacteria taxa and their products, which likely originates in desynchronization of intestinal clocks, promotes metabolic abnormalities during shift work.

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC9672454PMC
http://dx.doi.org/10.1016/j.molmet.2022.101628DOI Listing

Publication Analysis

Top Keywords

body weight
16
circadian disruption
12
shift work
12
weight gain
8
gut microbiome
8
microbiota dysbiosis
8
ssw-associated microbiota
8
loss rhythmicity
8
peripheral clock
8
microbiota
7

Similar Publications

Associations between variants in the FTO locus and plasma concentrations of appetite related hormones are inconsistent, and might not work in a dose dependent fashion in people with obesity. Moreover, it is relevant to report meal related plasma concentrations of these hormones in persons with obesity given the growing interest in their pharmacological potential in obesity therapy. We find it clinically relevant to examine associations between the SNP rs9939609 genotypes and homeostatic appetite regulation in individuals with BMI ≥35 kg/m2.

View Article and Find Full Text PDF

Modern treatment, a healthy diet, and physical activity routines lower the risk factors for metabolic syndrome; however, this condition is associated with all-cause and cardiovascular mortality worldwide. This investigation involved a randomized controlled trial, double-blind, parallel study. Fifty-eight participants with risk factors of metabolic syndrome according to the inclusion criteria were randomized into two groups and given probiotics (Lacticaseibacillus paracasei MSMC39-1 and Bifidobacterium animalis TA-1) (n = 31) or a placebo (n = 27).

View Article and Find Full Text PDF

Indigenous chickens play a crucial role in the livelihoods of smallholder farmers in rural Ethiopia. This study aimed to phenotypically characterize indigenous chickens in the Liban Jawi district, focusing on measurements of phenotypic characteristics. The multi-stage sampling method selected 192 households with at least two mature indigenous chickens from 2,166 households, resulting in the sampling of 224 chickens (138 females and 86 males) for phenotypic characterization.

View Article and Find Full Text PDF

Background: This study evaluates the efficacy and safety of sitagliptin versus gliclazide, combined with metformin, in treatment-naive patients with type 2 diabetes mellitus (T2DM) and glucotoxicity.

Methods: In this single-center, randomized, controlled noninferiority trial, 129 treatment-naive patients with T2DM with glucotoxicity (fasting plasma glucose [FPG] ≥ 200 mg/dL and glycated hemoglobin ≥ 9.0%) were randomized to receive sitagliptin plus metformin (n = 66) or gliclazide plus metformin (n = 63) for 12 weeks.

View Article and Find Full Text PDF

This study investigates the impact of twin intrahepatic cholestasis in pregnancy (ICP) in different chorionicity scenarios on pregnancy outcome and risk factors. This retrospective study was designed to investigate the association between ICP and pregnancy outcomes and associated risk factors. Logistic regression analysis was used to verify the correlation between ICP and pregnancy outcome and the associated risk factors with the risk of ICP.

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!